FI762875A - - Google Patents

Info

Publication number
FI762875A
FI762875A FI762875A FI762875A FI762875A FI 762875 A FI762875 A FI 762875A FI 762875 A FI762875 A FI 762875A FI 762875 A FI762875 A FI 762875A FI 762875 A FI762875 A FI 762875A
Authority
FI
Finland
Application number
FI762875A
Other languages
Finnish (fi)
Inventor
Lothar Ehrhardt
Volker Hartmann
Ludwig Patt
Karl-Heinz Otto
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of FI762875A publication Critical patent/FI762875A/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/48Ergoline derivatives, e.g. lysergic acid, ergotamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI762875A 1975-10-17 1976-10-08 FI762875A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2546577A DE2546577B2 (de) 1975-10-17 1975-10-17 Feste Stoffe aus Polyvinylpyrrolidon und Ergotalkaloiden

Publications (1)

Publication Number Publication Date
FI762875A true FI762875A (ja) 1977-04-18

Family

ID=5959411

Family Applications (1)

Application Number Title Priority Date Filing Date
FI762875A FI762875A (ja) 1975-10-17 1976-10-08

Country Status (28)

Country Link
JP (1) JPS5854122B2 (ja)
AT (1) AT362510B (ja)
AU (1) AU508628B2 (ja)
BE (1) BE847368A (ja)
CA (1) CA1079641A (ja)
CH (1) CH643737A5 (ja)
CS (1) CS199647B2 (ja)
DE (1) DE2546577B2 (ja)
DK (1) DK146194C (ja)
ES (1) ES452420A1 (ja)
FI (1) FI762875A (ja)
FR (1) FR2327764A1 (ja)
GB (1) GB1560406A (ja)
GR (1) GR61268B (ja)
HK (1) HK3183A (ja)
HU (1) HU172533B (ja)
IE (1) IE43778B1 (ja)
IL (1) IL50686A (ja)
MY (1) MY8400063A (ja)
NL (1) NL184558C (ja)
NO (1) NO144468C (ja)
NZ (1) NZ182341A (ja)
PH (1) PH14513A (ja)
PT (1) PT65719B (ja)
SE (1) SE430379B (ja)
SG (1) SG63082G (ja)
SU (1) SU1165223A3 (ja)
ZA (1) ZA766166B (ja)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1572226A (en) * 1977-11-03 1980-07-30 Hoechst Uk Ltd Pharmaceutical preparations in solid unit dosage form
US4411882A (en) 1978-12-21 1983-10-25 Sandoz Ltd. Galenical compositions
CH642259A5 (de) * 1978-12-21 1984-04-13 Sandoz Ag Galenische zubereitungen fuer orale applikation von ergotalkaloiden.
FR2454804B1 (fr) * 1979-04-26 1986-11-21 Sanofi Sa Medicament a base de dihydroergotoxine et son procede de preparation
US4366145A (en) * 1981-06-24 1982-12-28 Sandoz, Inc. Soft gelatin capsule with a liquid ergot alkaloid center fill solution and method of preparation
US4898729A (en) * 1983-12-09 1990-02-06 Euroceltique, S.A. Treatment of hypertension, compounds and compositions for antihypertension and diuresis
HU198844B (en) * 1984-06-14 1989-12-28 Sandoz Ag Process for producing new galenic pharmaceutical composition ensuring retarded release of active ingredient
EP0277092B1 (de) * 1987-01-14 1992-01-29 Ciba-Geigy Ag Therapeutisches System für schwerlösliche Wirkstoffe
FR2610827B1 (fr) * 1987-02-18 1991-09-13 Pf Medicament Comprime de dihydroergotamine (d.h.e.) du type a matrice hydrophile et son procede de fabrication
US5064656A (en) * 1989-11-14 1991-11-12 Dr. Gergely & Co. Uncoated pharmaceutical reaction tablet
DE4401646A1 (de) * 1994-01-21 1995-07-27 Krewel Werke Gmbh Optimal freisetzende Kava-Extrakte
US6524832B1 (en) 1994-02-04 2003-02-25 Arch Development Corporation DNA damaging agents in combination with tyrosine kinase inhibitors
HU229052B1 (en) * 1997-12-22 2013-07-29 Merck Sharp & Dohme Molecular dispersion composition with enhanced bioavailability
US6632455B2 (en) 1997-12-22 2003-10-14 Schering Corporation Molecular dispersion composition with enhanced bioavailability
US6316462B1 (en) 1999-04-09 2001-11-13 Schering Corporation Methods of inducing cancer cell death and tumor regression
US7771746B2 (en) 1999-12-03 2010-08-10 Polichem Sa Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof
ES2236017T3 (es) * 1999-12-03 2005-07-16 Polichem S.A. Procedimientos para la prepaaraciones farmaceuticas de liberacion sostenida de alcaloides del ergot que tienen biodfisponibilidad mejorada y composiciones de los mismos.
US7135436B2 (en) 2003-05-05 2006-11-14 J.F. Daley International, Ltd. Solid algicide, preparation and usage in recirculating water
DE60309356T2 (de) * 2003-06-27 2007-08-30 Bioprogress S.P.A. Zusammensetzung, durch zusammen vermahlen eines wirkstoffes mit einem n-vinyl-2-pyrrolidon/vinylacetatkopolymers erhältlich

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1175430A (en) * 1966-04-07 1969-12-23 Sandoz Ltd Pharmaceutical Compositions containing Ergot Alkaloids

Also Published As

Publication number Publication date
PH14513A (en) 1981-08-24
ES452420A1 (es) 1978-04-16
BE847368A (fr) 1977-04-15
NO763446L (ja) 1977-04-19
DE2546577A1 (de) 1977-04-21
SU1165223A3 (ru) 1985-06-30
DK146194C (da) 1984-01-02
PT65719A (fr) 1976-11-01
FR2327764B1 (ja) 1979-03-02
CA1079641A (en) 1980-06-17
DE2546577B2 (de) 1981-04-02
FR2327764A1 (fr) 1977-05-13
GB1560406A (en) 1980-02-06
DK146194B (da) 1983-07-25
HU172533B (hu) 1978-09-28
SG63082G (en) 1983-09-09
CS199647B2 (en) 1980-07-31
PT65719B (fr) 1978-06-12
NL184558C (nl) 1989-09-01
AU1875476A (en) 1978-04-20
IL50686A0 (en) 1976-12-31
ATA767976A (de) 1980-10-15
HK3183A (en) 1983-01-20
JPS5854122B2 (ja) 1983-12-02
JPS5251014A (en) 1977-04-23
AT362510B (de) 1981-05-25
AU508628B2 (en) 1980-03-27
IL50686A (en) 1979-05-31
SE7611189L (sv) 1977-04-18
ZA766166B (en) 1978-05-30
DK454176A (da) 1977-04-18
CH643737A5 (en) 1984-06-29
NO144468B (no) 1981-06-01
NO144468C (no) 1981-09-09
GR61268B (en) 1978-10-17
MY8400063A (en) 1984-12-31
NL7611295A (nl) 1977-04-19
NL184558B (nl) 1989-04-03
NZ182341A (en) 1978-09-20
IE43778B1 (en) 1981-05-20
IE43778L (en) 1977-04-17
SE430379B (sv) 1983-11-14

Similar Documents

Publication Publication Date Title
DK141899C (ja)
FR2327764B1 (ja)
FR2311091B1 (ja)
JPS5747579Y2 (ja)
CS174037B1 (ja)
JPS51105460U (ja)
CH600263A5 (ja)
CH340575A4 (ja)
CH604821A5 (ja)
CH604735A5 (ja)
CH604027A5 (ja)
CH603467A5 (ja)
CH603144A5 (ja)
CH602912A5 (ja)
CH602719A5 (ja)
BG22655A1 (ja)
CH602113A5 (ja)
CH607308A5 (ja)
CH600680A5 (ja)
CH609203A5 (ja)
CH600468A5 (ja)
CH600326A5 (ja)
CH606804A5 (ja)
CH600215A5 (ja)
CH599369A5 (ja)

Legal Events

Date Code Title Description
FC Application refused

Owner name: SANDOZ AG